Topic · page 16 of 18
Valvular & structural heart disease
Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure
Briefs in Valvular & structural heart disease
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Eur Heart J
JACC Cardiovasc Interv
Europace
J Am Coll Cardiol
J Am Coll Cardiol
Eur J Heart Fail
JACC Cardiovasc Interv
Eur Heart J
JACC Cardiovasc Interv
JAMA Cardiol
JACC Cardiovasc Interv
Eur Heart J
JACC Cardiovasc Imaging
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Lancet
J Am Coll Cardiol
JACC Cardiovasc Interv
JACC Cardiovasc Imaging
Eur J Heart Fail
Eur Heart J
JACC Cardiovasc Interv
1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation
Randomised controlled trial
Circulation
J Am Coll Cardiol
JACC Cardiovasc Interv
N Engl J Med
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
Randomised controlled trial
JACC Cardiovasc Interv
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Imaging
JACC Cardiovasc Interv
Eur J Heart Fail